VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Automatic Data Processing, Inc. vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Automatic Data Processing, Inc.
ADP · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Automatic Data Processing, Inc.'s moat claims, evidence, and risks.
View ADP analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 71 / 100 for Automatic Data Processing, Inc.).
- Segment focus: Automatic Data Processing, Inc. has 2 segments (67.5% in Employer Services); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: Automatic Data Processing, Inc. has 7 moat types across 4 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Automatic Data Processing, Inc.
Employer Services
Payroll processing and cloud HCM (HR, time, talent, tax, benefits) software and outsourcing
Global
Businesses (SMB to large enterprise)
SaaS and managed services provider
67.5%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Automatic Data Processing, Inc. strengths
Novo Nordisk A/S strengths
Segment mix
Automatic Data Processing, Inc. segments
Full profile >Employer Services
Oligopoly
Professional Employer Organization (PEO) Services
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.